Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Bemotrizinol in Human Repeated Insult Patch Test (HRIPT) and Cumulative Irritation Test

NCT05260359 is registered in ClinicalTrials.gov with dsm-firmenich Switzerland AG as lead sponsor.

NCT NCT05260359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Bemotrizinol in Human Repeated Insult Patch Test (HRIPT) and Cumulative Irritation Test
Lead sponsor
dsm-firmenich Switzerland AG
Phase
Phase 2
Overall status
Completed
Start date
February 23, 2022
Completion date
April 8, 2022
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sunburn